Central Bank & Trust’s Chemed CHE Stock Holding History

Central Bank & Trust’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-65	Closed	-$31K	–	302
2021 Q2	$31K	Hold	65	–	–	0.01%	242
2021 Q1	$30K	Buy	+65	New	+$31.9K	0.01%	233

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Central Bank & Trust's CHE Position: Q3 2021 in Review

Central Bank & Trust sold out of Chemed (CHE) in Q3 2021, closing a stake of 65 shares — an estimated $31K sold.

Central Bank & Trust first reported a position in CHE in Q1 2021 and held it in 2 quarters. The position peaked at $31K in Q2 2021. 403 funds tracked by Wall St. Rank hold CHE as of Q3 2021.

Central Bank & Trust reported no remaining Chemed position as of Q3 2021 after selling out during the quarter.
Central Bank & Trust sold 65 Chemed shares in Q3 2021, an estimated $31K.
Central Bank & Trust first reported a position in Chemed in Q1 2021 and held it in 2 quarters.
Central Bank & Trust's Chemed position peaked at $31K in Q2 2021.
403 funds tracked by Wall St. Rank held Chemed as of Q3 2021.

Based on Central Bank & Trust's 13F filing for Q3 2021, filed 19 Oct 2021.